On September 15, 2021, the Continuing Medical Education (CME) Coalition penned a letter of support to Rep. Cathy McMorris Rodgers (R-WA) endorsing the Lower Costs, More Cures Act of 2021 (H.R. 19). Introduced in the House on April 22, this bill includes a provision that would require the Department of Health and Human Services (HHS) to advance education and awareness among health providers regarding biosimilars, including by developing and improving continuing education programs
“The CME Coalition wholeheartedly endorses your legislation and believes that continuing medical education is an effective way to drive greater uptake of safe and effective biosimilars,” wrote CME Coalition Executive Director Andrew Rosenberg. “We thank you for your support on this important issue, and look forward to working with you to drive greater support for the bill, as well as serving as a subject matter resource to you as the legislative process continues.”
| cme_mcmorris_rodgers_support_letter.pdf |
